Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2025-12-25 @ 8:52 PM
Study NCT ID:
NCT00065156
Status:
COMPLETED
Last Update Posted:
2019-11-19
First Post:
2003-07-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2008-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2003-07-17
First Submit QC Date:
None
Study First Post Date:
2003-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-08-31
Results First Submit QC Date:
None
Results First Post Date:
2010-06-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-06
Last Update Post Date:
2019-11-19
Last Update Post Date Type:
ACTUAL